A service of arranging or bringing about contact between an investment manager and an issuer or potential issuer.
ENGLEWOOD, Colo., July 13, 2017 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced the signing of an exclusive distribution agreement for...
ENGLEWOOD, Colo., July 5, 2017 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced seven presentations at the European Society of Human Reproduction...
ENGLEWOOD, Colo., June 19, 2017 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced the hiring of Gregory A. Gould as the company's full-time Chief...
ENGLEWOOD, Colo., May 17, 2017 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced that it presented one poster presentation illustrating safety...
ENGLEWOOD, Colo., May 15, 2017 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced that it presented two posters demonstrating new clinical findings...
Live Conference Call and Webcast TODAY at 4:30 p.m. ETENGLEWOOD, Colo., May 11, 2017 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, today provided an overview of...
ENGLEWOOD, Colo., May 9, 2017 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, today announced the acquisition of Nuelle, Inc. ('Nuelle"), a women's sexual health...
Live Conference Call and Webcast Scheduled for May 11, 2017, at 4:30 p.m. ETENGLEWOOD, Colo., May 3, 2017 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today...
ENGLEWOOD, Colo., April 4, 2017 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced that it presented two posters demonstrating the safety advantages...
Sale Price of $1.75 Million in Cash Further Supports Ongoing Commercialization of Natesto®ENGLEWOOD, Colo., April 3, 2017 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field...